Format

Send to

Choose Destination
Rev Soc Bras Med Trop. 2014 Mar-Apr;47(2):227-30.

Hybrid capture II and PapilloCheck® tests for detection of anal high-risk human papillomavirus.

Author information

1
Departamento de Patologia, Hospital Universitário de Brasília, Brasília, DF.
2
Departamento de Biologia Molecular, Laboratório Sabin, Brasília, DF.
3
Serviço de Coloproctologia, Hospital Universitário de Brasília, Brasília, DF.

Abstract

INTRODUCTION:

This study evaluated the level of concordance between hybrid capture II (HCII) and PapilloCheck® for the detection of high-risk human papillomavirus (HPV) in anal samples.

METHODS:

Anal cell samples collected from 42 human immunodeficiency virus (HIV)+ patients were analyzed.

RESULTS:

Considering only the 13 high-risk HPV types that are detectable by both tests, HCII was positive for 52.3% of the samples, and PapilloCheck® was positive for 52.3%. The level of concordance was 80.9% (Kappa = 0.61).

CONCLUSIONS:

Good concordance was observed between the tests for the detection of high-risk HPV.

PMID:
24861299
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Scientific Electronic Library Online
Loading ...
Support Center